Literature DB >> 31328105

BI-RADS 4 breast lesions: could multi-mode ultrasound be helpful for their diagnosis?

Gang Liu1, Meng-Ke Zhang2, Yan He2, Yuan Liu2, Xi-Ru Li3, Zhi-Li Wang2.   

Abstract

BACKGROUND: The malignant probability of Breast Imaging Reporting and Data System (BI-RADS) 4 breast lesions is 3-94%, which is a very large span, and thus leads to a high rate of unnecessary biopsy. Therefore, the differential diagnosis of benign and malignant BI-RADS 4 breast lesions has become extremely important. Thus, in this paper, we investigated the diagnostic value of conventional ultrasonography (US), contrast-enhanced ultrasound (CEUS) and shear wave elastography (SWE) for BI-RADS 4 breast lesions, and tried to figure out a multi-mode ultrasonic method for them.
METHODS: From March 2016 to May 2017, 118 breast lesions that were categorized as BI-RADS 4 lesions by US were studied with CEUS and SWE. All the lesions were confirmed by pathology via surgery or vacuum-assisted biopsy. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of US, CEUS and SWE were analyzed. Then the diagnostic efficacies of US, CEUS, SWE and the combination of these modalities were compared. Logistic regression analysis was performed to identify the independent risk factors. A multi-mode method to evaluate BI-RADS 4 lesions based on the logistic regression was developed.
RESULTS: Of the 118 BI-RADS 4 lesions, 74 lesions (62.7%) were benign and 44 lesions (37.3%) were malignant. The diagnostic sensitivity and specificity for US, US + CEUS, US + SWE, US + CEUS + SWE were 88.6% and 75.7%, 86.4% and 94.6%, 88.6% and 90.5%, 97.7% and 93.2%, respectively. The area under the ROC curve (AUC) of US + SWE + CEUS was significantly higher than that of US (P<0.0001), US + CEUS (P=0.020), but there was no significant difference between the AUC of US + SWE + CEUS and the AUC of US + SWE.
CONCLUSIONS: US + CEUS + SWE and US + SWE could significantly improve the diagnostic efficiency and accuracy of US in the diagnosis of BI-RADS 4 breast lesions.

Entities:  

Keywords:  Breast Imaging Reporting and Data System (BI-RADS); Contrast-enhanced ultrasound (CEUS); breast lesions; shear wave elastography (SWE)

Year:  2019        PMID: 31328105      PMCID: PMC6606479          DOI: 10.21037/gs.2019.05.01

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  30 in total

1.  The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications.

Authors:  F Piscaglia; C Nolsøe; C F Dietrich; D O Cosgrove; O H Gilja; M Bachmann Nielsen; T Albrecht; L Barozzi; M Bertolotto; O Catalano; M Claudon; D A Clevert; J M Correas; M D'Onofrio; F M Drudi; J Eyding; M Giovannini; M Hocke; A Ignee; E M Jung; A S Klauser; N Lassau; E Leen; G Mathis; A Saftoiu; G Seidel; P S Sidhu; G ter Haar; D Timmerman; H P Weskott
Journal:  Ultraschall Med       Date:  2011-08-26       Impact factor: 6.548

2.  Factors affecting nodal status in invasive breast cancer: a retrospective analysis of 623 patients.

Authors:  Emma Aitken; Monzir Osman
Journal:  Breast J       Date:  2010-02-23       Impact factor: 2.431

3.  The role of contrast enhanced MRI in the diagnosis of non-mass image-forming lesions on breast ultrasonography.

Authors:  Keiichi Sotome; Yuki Yamamoto; Atsushi Hirano; Takeshi Takahara; Sayuri Hasegawa; Makoto Nakamaru; Akio Furukawa; Hiroshi Miyazaki; Kyoei Morozumi; Tatsuya Onishi; Yoichi Tanaka; Hisami Iri
Journal:  Breast Cancer       Date:  2007       Impact factor: 4.239

4.  Reproducibility of the assessment of tumor extent in the breast using multiple image modalities.

Authors:  William F A Klein Zeggelink; Eline E Deurloo; Harry Bartelink; Emiel J Th Rutgers; Kenneth G A Gilhuijs
Journal:  Med Phys       Date:  2003-11       Impact factor: 4.071

5.  Accuracy of classification of breast ultrasound findings based on criteria used for BI-RADS.

Authors:  J Heinig; R Witteler; R Schmitz; L Kiesel; J Steinhard
Journal:  Ultrasound Obstet Gynecol       Date:  2008-09       Impact factor: 7.299

6.  Detection and quantification of breast tumor necrosis with MR imaging: value of the necrosis-avid contrast agent Gadophrin-3.

Authors:  Stephan Metz; Heike E Daldrup-Unk; Thomas Richter; Christoph Räth; Wolfgang Ebert; Marcus Settles; Ernst J Rummeny; Thomas M Link; Morand Piert
Journal:  Acad Radiol       Date:  2003-05       Impact factor: 3.173

7.  Correlation of real-time gray scale contrast-enhanced ultrasonography with microvessel density and vascular endothelial growth factor expression for assessment of angiogenesis in breast lesions.

Authors:  Jing Du; Feng-Hua Li; Hua Fang; Jian-Guo Xia; Cai-Xia Zhu
Journal:  J Ultrasound Med       Date:  2008-06       Impact factor: 2.153

8.  BI-RADS 3, 4, and 5 lesions: value of US in management--follow-up and outcome.

Authors:  Sughra Raza; Sona A Chikarmane; Sarah S Neilsen; Lisa M Zorn; Robyn L Birdwell
Journal:  Radiology       Date:  2008-07-22       Impact factor: 11.105

9.  Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.

Authors:  Hongjia Zhao; Rong Xu; Qiufang Ouyang; Lidian Chen; Baowei Dong; Ye Huihua
Journal:  Eur J Radiol       Date:  2009-06-25       Impact factor: 3.528

10.  Quantitative shear wave ultrasound elastography: initial experience in solid breast masses.

Authors:  Andrew Evans; Patsy Whelehan; Kim Thomson; Denis McLean; Katrin Brauer; Colin Purdie; Lee Jordan; Lee Baker; Alastair Thompson
Journal:  Breast Cancer Res       Date:  2010-12-01       Impact factor: 6.466

View more
  4 in total

1.  Correlation of elastic characteristics of breast lesions with the expression of Smad2/3.

Authors:  Meng-Ke Zhang; Shi-Yu Li; Shao-Wei Xue; Gang Liu; Zhi-Li Wang
Journal:  Ann Transl Med       Date:  2021-11

2.  Value of magnetic resonance diffusion combined with perfusion imaging techniques for diagnosing potentially malignant breast lesions.

Authors:  Hui Zhang; Xin-Yi Zhang; Yong Wang
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

3.  The role of contrast-enhanced ultrasound in the diagnosis of malignant non-mass breast lesions and exploration of diagnostic criteria.

Authors:  Fan Zhang; Lifang Jin; Gang Li; Chao Jia; Qiusheng Shi; Lianfang Du; Rong Wu
Journal:  Br J Radiol       Date:  2021-02-09       Impact factor: 3.039

4.  Superb Microvascular Imaging Technology Can Improve the Diagnostic Efficiency of the BI-RADS System.

Authors:  Siman Cai; Hongyan Wang; Xiaoyan Zhang; Li Zhang; Qingli Zhu; Qiang Sun; Jianchu Li; Yuxin Jiang
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.